Mutating factor VIII: lessons from structure to function

被引:44
作者
Fay, PJ
Jenkins, PV
机构
[1] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[3] Royal Free Hosp, Katharine Dormandy Haemophilia Ctr, London NW3 2QG, England
[4] Royal Free Hosp, Haemostasis Unit, London NW3 2QG, England
关键词
factor VIII; factor VIIIa; factor IXa; intrinsic factor Xase; site-directed mutagenesis; CRM+ hemophilia;
D O I
10.1016/j.blre.2004.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor VIII, a metal ion-dependent heterodimer, circulates in complex with von Willebrand factor. At sites of vessel wall damage, this procofactor is activated to factor Villa by limited proteolysis and assembles onto an anionic phospholipid surface in complex with factor Na to form the an enzyme complex that efficiently converts factor X to factor Xa during the propagation phase of coagulation. Factor Xase activity is down-regulated by mechanisms that include self-dampening by dissociation of a critical factor Villa subunit and proteolytic inactivation by the activated protein C pathway. Recent studies identify putative metal ion coordination sites as well as ligands involved in the catabolism of the activated and procofactor forms of the protein. Our knowledge of these multiple intra- and inter-molecular interactions has been facilitated by the application of naturally occurring and site-directed mutations to study factor VIII structure and function. In this review, we document important and novel contributions following this line of investigation. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15 / 27
页数:13
相关论文
共 88 条
[11]   THE ROLE OF CLEAVAGE OF THE LIGHT-CHAIN AT POSITIONS ARG(1689) OR ARG(1721) IN SUBUNIT INTERACTION AND ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-VIII [J].
DONATH, MJSH ;
LENTING, PJ ;
VANMOURIK, JA ;
MERTENS, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :3648-3655
[12]   FAMILIAL DISCREPANCY BETWEEN THE ONE-STAGE AND 2-STAGE FACTOR-VIII METHODS IN A SUBGROUP OF PATIENTS WITH HEMOPHILIA-A [J].
DUNCAN, EM ;
DUNCAN, BM ;
TUNBRIDGE, LJ ;
LLOYD, JV .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :846-848
[13]   Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII [J].
Esmon, CT ;
Lollar, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13882-13887
[14]   Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa [J].
Fay, PJ ;
Scandella, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :29826-29830
[15]  
FAY PJ, 1994, J BIOL CHEM, V269, P20522
[16]   Activation of factor VIII and mechanisms of cofactor action [J].
Fay, PJ .
BLOOD REVIEWS, 2004, 18 (01) :1-15
[17]   Cleavage of factor VIII heavy chain is required for the functional interaction of A2 subunit with factor IXa [J].
Fay, PJ ;
Mastri, M ;
Koszelak, ME ;
Wakabayashi, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :12434-12439
[18]   RECONSTITUTION OF HUMAN FACTOR-VIII FROM ISOLATED SUBUNITS [J].
FAY, PJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 262 (02) :525-531
[19]   New insights into binding interfaces of coagulation factors V and VIII and their homologues - Lessons from high resolution crystal structures [J].
Fuentes-Prior, P ;
Fujikawa, K ;
Pratt, KP .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2002, 3 (03) :313-339
[20]   An engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa [J].
Gale, AJ ;
Pellequer, JL .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) :1966-1971